Ex vivo recapitulation of trauma-induced coagulopathy and preliminary assessment of trauma patient platelet function under flow using microfluidic technology

Journal of Trauma and Acute Care Surgery

Volumn 80, Issue 3, 2016, Pages 440-449

  Li, Ruizhi ^a   Elmongy, Hanna ^a   Sims, Carrie ^b   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bleeding; Diagnostics; Flow assays; Microfluidics; Platelet function

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; EX VIVO STUDY; FEMALE; FIBRIN DEPOSITION; HEMATOCRIT; HEMODILUTION; HUMAN; INJURY; MALE; MICROFLUIDICS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; TRAUMA INDUCED COAGULOPATHY; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD COAGULATION DISORDERS; COMPLICATION; FLOW CYTOMETRY; PHYSIOLOGY; PROCEDURES; THROMBOCYTE;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; PLATELET FUNCTION TESTS; WOUNDS AND INJURIES;

EID: 84960420991     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000915     Document Type: Article

References (31)

1. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65(4):748-754.
2. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet J-F. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007;245(5):812-818.
3. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost. 2007;5(2):289-295.
4. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10(7):1342-1351.
5. Kutcher ME, Redick BJ, McCreery RC, Crane IM, Greenberg MD, Cachola LM, Nelson MF, Cohen MJ. Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg. 2012;73(1):13-19.
6. Solomon C, Traintinger S, Ziegler B, Hanke A, Rahe-Meyer N, Voelckel W, Schochl H. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost. 2011;106(9):322-330.
7. Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG. Platelet activation and function after trauma. J Trauma. 2001;51(4): 639-647.
8. Wohlauer MV, Moore EE, Thomas S, Sauaia A, Evans E, Harr J, Silliman CC, Ploplis V, Castellino FJ, Walsh M. Early platelet dysfunction: An unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg. 2012;214(5):739-746.
9. Davis PK, Musunuru H, Walsh M, Cassady R, Yount R, Losiniecki A, Moore EE, Wohlauer MV, Howard J, Ploplis VA, et al. Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy. Neurocrit Care. 2013;18(2):201-208.
10. Colace TV, Fogarty PF, Panckeri KA, Li R, Diamond SL. Microfluidic assay of hemophilic blood clotting: Distinct deficits in platelet and fibrin deposition at low factor levels. J Thromb Haemost. 2014;12(2):147-158.
11. Maloney SF, Brass LF, Diamond SL. P2-12 or P2-1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions. Integr Biol (Camb). 2010;2(4):183-192.
12. Colace TV, Muthard RW, Diamond SL. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol. 2012;32(6):1466-1476.
13. Rana K, Timmer BJ, Neeves KB. A combined microfluidic-microstencil method for patterning biomolecules and cells. Biomicro fluidics. 2014;8 (5):056502.
14. DeWitt SM, Swieringa F, Cavill R, Lamers MME, van Kruchten R, Mastenbroek T, Baaten C, Coort S, Pugh N, Schulz A, et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun. 2014;16(5):4257.
15. Kuijpers MJE, Van Der Meijden PEJ, Feijge MA, Mattheij NJ, May F, Govers-Riemslag J, Meijers JC, Heemskerk JW, Renne T, Cosemans JM. Factor XII regulates the pathological process of thrombus formation on ruptured plaques. Arterioscler Thromb Vasc Biol. 2014;34(8):1674-1680.
16. Onasoga-Jarvis AA, Leiderman K, Fogelson AL, Wang M, Manco-Johnson MJ, Di Paola JA, Neeves KB. The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models. PLoS One. 2013;8(11):e78732.
17. Li R, Panckeri KA, Fogarty PF, Diamond SL. Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition. Haemophilia. 2015;21 (2):266-274.
18. Li X, Fries S, Li R, Lawson JA, Propert KJ, Diamond SL, Blair IA, FitzGerald GA, Grosser T. Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA. 2014;111(47):16830-16835.
19. Johansson PI, Stensballe J, Oliveri R, Wade CE, Ostrowski SR, Holcomb JB. How I treat patients with massive hemorrhage. Blood. 2014;124:3052-3058.
20. Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology. 2010;113(5):1205-1219.
21. Sperry JL, Ochoa JB, Gunn SR, Alarcon LH, Minei JP, Cuschieri J, Rosengart MR, Maier RV, Billiar TR, Peitzman AB, et al. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma. 2008;65(5):986-993.
22. Sihler KC, Napolitano LM. Massive transfusion: New insights. Chest. 2009; 136(6):1654-1667.
23. Neeves KB, Maloney SF, Fong KP, Schmaier AA, Kahn ML, Brass LF, Diamond SL. Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear-resistance of platelet aggregates. J Thromb Haemost. 2008;6(12):2193-2201.
24. Chatterjee MS, Denney WS, Jing H, Diamond SL. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol. 2010;6(9):e1000950.
25. Whelihan MF, Mann KG. The role of the red cell membrane in thrombin generation. Thromb Res. 2013;131(5):377-382.
26. Stein SC, Smith DH. Coagulopathy in traumatic brain injury. Neurocrit Care. 2004;1(27):479-488.
27. Teodoro L, Nascimento B, Rizoli S. Thrombelastography (TEG): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med. 2013;16(21):29.
28. Neeves KB, Illing DA, Diamond SL. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J. 2010;98(7):1344-1352.
29. Haynes LM, Dubief YC, Orfeo T, Mann KG. Dilutional control of prothrombin activation at physiologically relevant shear rates. Biophys J. 2011;100(3):765-773.
30. Bender M, Hofmann S, Stegner D, Chalaris A, Bösl M, Braun A, Scheller J, Rose-John S, Niewandt B. Differentially regulated GPVI ectodomain shedding by multiple plateletexpressed proteinases Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood. 2010;116(17):3347-3355.
31. Bergmeier W, Piffath CL, Cheng G, Dole VS, Zhang Y, Von Andrian UH, Wagner DD. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res. 2004;95(7):677-683.